UPDATE ON INVESTMENT

AI SummaryClose X

BioPharma Credit PLC has announced an increased loan agreement with UroGen Pharma Ltd., amending their senior secured loan facility from US$125 million to up to US$250 million. The Company's allocation has increased to US$100 million for Tranche A and US$25 million for Tranche B, with a fixed interest rate of 8.25% per annum. UroGen also paid US$8.6 million in make-whole and prepayment fees, from which BioPharma Credit received US$3.0 million. The new Tranche B is available until June 2027, and a 1.50% additional consideration was received on Tranche A funding.

Disclaimer*

UK 100